N | % or mean (SD) | |
---|---|---|
Socio-demographic and lifestyle factors | ||
Age (years, mean, SD) | 395 | 60.7 (6.9) |
Caucasian (%) | 385 | 91.9 |
Education (%) | 385 | |
High school degree or less | 16.4 | |
Some college | 30.9 | |
College degree | 23.9 | |
Post graduate | 28.8 | |
Household income (%) | 365 | |
< $50,000 | 18.3 | |
$50,000—< $75,000 | 20.3 | |
≥ $75,000 | 61.4 | |
Married or living with a partner (%) | 395 | 82.5 |
Smoking (%) | 385 | |
Never smoker | 62.5 | |
Former smoker | 32.7 | |
Current smoker | 6.8 | |
Charlson Comorbidity Index (%) | 394 | |
No comorbidities | 16.2 | |
Any comorbidities | 26.2 | |
Missing | 57.6 | |
Prostate cancer- and surgery-related factors | ||
Clinical T1 stage (%) | 381 | 78.5 |
Pathological stage (%) | 389 | |
T2 | 11.1 | |
T3 | 88.9 | |
Pre-surgical prostate-specific antigen concentration (ng/mL, mean, SD) | 393 | 6.3 (4.6) |
Blood loss during surgery (mL, mean, SD) | 358 | 246.3 (203.3) |
Neurovascular bundle preservation (%) | 351 | |
Non-nerve sparing | 19.4 | |
Unilateral neurovascular bundle spared | 15.4 | |
Bilateral nerve sparing | 65.2 | |
Surgical procedure (%) | 365 | |
Minimally-invasive (robotic and laparoscopic) | 92.3 | |
Open | 7.7 | |
Bladder reconstruction | 364 | 53.0 |
BPH-related factors | ||
Prostate size (grams, mean, SD) | 288 | 43.5 (16.6) |
IPSS score at baseline (mean, SD) | 249 | 8.6 (6.7) |
BPH medication use at baseline (%) | 395 | 13.2 |
α-blocker use | 10.4 | |
5α-reductase inhibitor (and α-blocker) use | 2.8 | |
Urinary and sexual function-related factors | ||
Reported Kegel exercises | ||
5 weeks post-surgery | 358 | 67.3 |
12 months post-surgery | 332 | 31.3 |
ED medication or device use (%) | ||
Baseline | 365 | 4.8 |
5 weeks post-surgery | 365 | 30.1 |
12 months post-surgery | 336 | 18.2 |